Safety, Tolerability, and Pharmacokinetics of ICL670, a New Orally Active Iron-Chelating Agent in Patients with Transfusion-Dependent Iron Overload Due to β-Thalassemia
- 1 June 2003
- journal article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 43 (6) , 565-532
- https://doi.org/10.1177/0091270003043006002
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: